Search

Search Constraints

You searched for: Author/Creator Mirzaei, Sepideh

Search Results

1. (Nano)platforms in bladder cancer therapy: Challenges and opportunities. Issue 1 (17th June 2022)

2. Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects. Issue 2 (February 2022)

3. Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges. (January 2023)

4. Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer. (September 2021)

5. Chitosan‐based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy. Issue 1 (13th September 2022)

6. Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects. (25th October 2021)

7. Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance. (3rd April 2022)

8. Elevated CDK5R1 expression associated with poor prognosis, proliferation, and drug resistance in colorectal and breast malignancies: CDK5R1 as an oncogene in cancers. (1st December 2022)

9. Epigenetic regulation of autophagy by non-coding RNAs in gastrointestinal tumors: Biological functions and therapeutic perspectives. (January 2023)

10. Gallic acid for cancer therapy: Molecular mechanisms and boosting efficacy by nanoscopical delivery. (November 2021)